Emerging roles of secreted phospholipase A2 enzymes: An update

Biochimie

Volumn 95, Issue 1, 2013, Pages 43-50

  Murakami, Makoto ^a   Lambeau, Gérard ^b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Arachidonic acid; Atherosclerosis; Inflammation; Lipid

Indexed keywords

CERVONIC ACID; DOCOSAPENTAENOIC ACID; ESTERASE INHIBITOR; ICOSANOID; LINOLEOYL COENZYME A DESATURASE; LIVER X RECEPTOR; LYSOPHOSPHATIDYLCHOLINE; MATRIX METALLOPROTEINASE; PEPTIDOLEUKOTRIENE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOLIPASE A2 GROUP V; POLYUNSATURATED FATTY ACID; SECRETORY PHOSPHOLIPASE A2; UNCLASSIFIED DRUG; VARESPLADIB; VARESPLADIB METHYL; VERY LOW DENSITY LIPOPROTEIN; VISTA 16;

ADAPTIVE IMMUNITY; ALOPECIA; ANTIBACTERIAL ACTIVITY; ARTHRITIS; ASTHMA; C57BL 6 MOUSE; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; DOWN REGULATION; EPIDERMIS HYPERPLASIA; EPIDIDYMIS; EPITHELIOID CELL; ESCHERICHIA COLI; GENE LOCUS; GENE MUTATION; GENE SILENCING; GENETIC POLYMORPHISM; HAIR GROWTH; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HOST RESISTANCE; HUMAN; HYPERLIPIDEMIA; HYPOTHERMIA; IN VIVO STUDY; INNATE IMMUNITY; INNER EAR; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIVER TOXICITY; LUNG ALVEOLUS EPITHELIUM; LUNG INFECTION; METABOLIC DISORDER; MICROENVIRONMENT; MOLECULAR PATHOLOGY; NERVE CELL; NEUTROPHIL; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; RESPIRATORY ACIDOSIS; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT INFLAMMATION; REVIEW; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; SKIN CANCER; SPERMATOZOON CAPACITATION; SPERMATOZOON MATURATION; SPINAL CORD INJURY; SPINAL GANGLION; SYNOVIAL FLUID; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

MAMMALIA;

EID: 84870518212     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.09.007     Document Type: Short Survey

References (96)

1. 2 Annu. Rev. Biochem. 77 2008 495 520
2. 2 enzymes: lessons from transgenic and knockout mice Biochimie 92 2010 561 582
3. 2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention Chem. Rev. 111 2011 6130 6185
4. 2 research: from cells to animals to humans Prog. Lipid Res. 50 2011 152 192
5. 2 revisited J. Biochem. 150 2011 233 255
6. 2 in allergen-induced airway inflammation and remodeling in a mouse asthma model J. Exp. Med. 204 2007 865 877
7. 2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice J. Immunol. 179 2007 4800 4807
8. 2 inhibitor J. Biol. Chem. 286 2011 28049 28055
9. 2 group X J. Biol. Chem. 285 2010 41491 41500
10. 2 proenzyme is matured by a furin-like proprotein convertase and releases arachidonic acid inside of human HEK293 cells J. Biol. Chem. 286 2011 36509 36521
11. 2 groups IIA and X in the airways and asthma severity Clin. Exp. Allergy 41 2011 801 810
12. 2 in mice leads to neonatal lethality because of lung dysfunction J. Biol. Chem. 281 2006 36420 36433
13. 2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis J. Biol. Chem. 281 2006 6691 6698
14. 2 reveals its role in house dust mite-induced allergic pulmonary inflammation by regulation of dendritic cell function J. Immunol. 185 2010 4430 4438
15. 2 contributes to LPS-induced leukocyte recruitment J. Cell. Physiol. 224 2010 127 134
16. 2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia J. Biol. Chem. 286 2011 35650 35662
17. 2 modulates phagosome maturation and regulates the innate immune response against Candida albicans J. Immunol. 182 2009 4891 4898
18. 2 in immune complex-mediated arthritis EMBO Mol. Med. 2 2010 172 187
19. 2 is an endogenous antibiotic-like protein of the host Biochimie 92 2010 583 587
20. 2: role of Streptococcus pyogenes sortase A J. Immunol. 187 2011 6437 6446
21. 2 expression through MAPK/NF-κB inactivation Biochem. Pharmacol. 79 2010 1149 1155
22. 2 gene in inbred mouse strains J. Biol. Chem. 270 1995 22378 22385
23. Min-induced intestinal neoplasia Cell 81 1995 957 966
24. 2 to Escherichia coli infection Infect. Immun. 68 2000 87 92
25. 2 against experimental anthrax J. Immunol. 175 2005 6786 6791
26. 2 J. Clin. Invest. 102 1998 633 638
27. 2 Biochim. Biophys. Acta 1781 2008 1 9
28. 2 J. Biol. Chem. 269 1994 2365 2368
29. 2 plays a pathogenic role in myocardial ischaemia-reperfusion injury Cardiovasc. Res. 90 2011 335 343
30. 2-deficient mice Circulation 117 2008 2977 2985
31. 2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis J. Biol. Chem. 277 2002 5061 5073
32. 2 inhibitor varespladib (A-002) J. Lipid Res. 50 2009 623 629
33. 2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial Lancet 373 2009 649 658
34. 2 inhibitor, reduces atherosclerosis in guinea pigs BMC Cardiovasc. Disord. 9 2009 7
35. R.S. Rosenson After FRANCIS: next steps in the clinical evaluation of varespladib methyl Future Cardiol. 7 2011 11 18
36. 2 inhibitor for the potential treatment of coronary artery disease IDrugs 12 2009 585 592
37. 2 is associated with abdominal aortic aneurysm presence but not progression Atherosclerosis 216 2011 458 460
38. 2 predict coronary events in patients with coronary artery disease Circulation 100 1999 1280 1284
39. 2 in cardiovascular disease: roles as biological effectors and biomarkers Circulation 122 2010 2183 2200
40. 2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans J. Biol. Chem. 280 2005 32746 32752
41. 2 is linked to macrophage foam cell formation J. Biol. Chem. 277 2002 29116 29124
42. 2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis J. Biol. Chem. 283 2008 33483 33497
43. 2 on human endothelial cell function FASEB J. 20 2006 2547 2549
44. 2 induces dendritic cell maturation through lipoprotein-dependent and -independent mechanisms Atherosclerosis 222 2012 367 374
45. 2 promotes atherosclerosis: evidence from genetically altered mice Arterioscler. Thromb. Vasc. Biol. 27 2007 600 606
46. 2 augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice Atherosclerosis 214 2011 58 64
47. 2 in neutrophils plays a pathogenic role in abdominal aortic aneurysms in mice Am. J. Physiol. Heart Circ. Physiol. 302 2012 H95 H104
48. 2 transgenic mice spontaneously develop inflammation Biochem. J. 421 2009 17 27
49. 2-deficient mice Am. J. Physiol. Endocrinol. Metab. 283 2002 E994 E1001
50. 2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia Diabetes 55 2006 935 941
51. N.I. Hollie, and D.Y. Hui Group 1B phospholipase A deficiency protects against diet-induced hyperlipidemia in mice J. Lipid Res. 52 2011 2005 2011
52. 2 in reproduction, gastrointestinal phospholipid digestion, and neuronal function J. Biol. Chem. 286 2011 11632 11648
53. 2 inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice Br. J. Pharmacol. 157 2009 1263 1269
54. 2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages Arterioscler. Thromb. Vasc. Biol. 30 2010 2014 2021
55. 2 regulates the expression of steroidogenic acute regulatory protein (StAR) in mouse adrenal glands J. Biol. Chem. 285 2010 20031 20039
56. 2 enhances TLR4 signaling in macrophages J. Immunol. 187 2011 482 489
57. 2 negatively regulates adipogenesis in murine models FASEB J. 24 2010 4313 4324
58. 2 lacking enzymatic activity Biochemistry 42 2003 11494 11503
59. 2 GXIIB Hepatology 53 2011 458 466
60. W. Stoffel, B. Holz, B. Jenke, E. Binczek, R.H. Gunter, C. Kiss, I. Karakesisoglou, M. Thevis, A.A. Weber, S. Arnhold, and K. Addicks Δ6-desaturase (FADS2) deficiency unveils the role of ω3- and ω6-polyunsaturated fatty acids EMBO J. 27 2008 2281 2292
61. S. Huyghe, H. Schmalbruch, K. De Gendt, G. Verhoeven, F. Guillou, P.P. Van Veldhoven, and M. Baes Peroxisomal multifunctional protein 2 is essential for lipid homeostasis in Sertoli cells and male fertility in mice Endocrinology 147 2006 2228 2236
62. M. Roqueta-Rivera, C.K. Stroud, W.M. Haschek, S.J. Akare, M. Segre, R.S. Brush, M.P. Agbaga, R.E. Anderson, R.A. Hess, and M.T. Nakamura Docosahexaenoic acid supplementation fully restores fertility and spermatogenesis in male Δ-6 desaturase-null mice J. Lipid Res. 51 2010 360 367
63. A. Koeberle, H. Shindou, T. Harayama, K. Yuki, and T. Shimizu Polyunsaturated fatty acids are incorporated into maturating male mouse germ cells by lysophosphatidic acid acyltransferase 3 FASEB J. 26 2012 169 180
64. 2 regulates epididymal sperm maturation and fertility in mice J. Clin. Invest. 120 2010 1400 1414
65. 2 is released during sperm acrosome reaction and controls fertility outcome in mice J. Clin. Invest. 120 2010 1415 1428
66. 2 superfamily in experimental autoimmune encephalomyelitis Brain 132 2009 1221 1235
67. 2 superfamily members play divergent roles after spinal cord injury FASEB J. 25 2011 4240 4252
68. 2 J. Biol. Chem. 280 2005 23203 23214
69. 2 stimulates the proliferation of colon cancer cells by producing various lipid mediators Mol. Pharmacol. 76 2009 778 790
70. 2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice Eur. J. Pharmacol. 518 2005 56 62
71. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate J. Clin. Invest. 97 1996 2233 2241
72. 2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis Oncogene 22 2003 1936 1944
73. 2 in mouse skin J. Biol. Chem. 286 2011 11616 11631
74. U. Haas, M. Podda, M. Behne, S. Gurrieri, A. Alonso, G. Furstenberger, J. Pfeilschifter, G. Lambeau, M.H. Gelb, and M. Kaszkin Characterization and differentiation-dependent regulation of secreted phospholipases A in human keratinocytes and in healthy and psoriatic human skin J. Invest. Dermatol. 124 2005 204 211
75. 2 in murine epidermis J. Invest. Dermatol. 121 2003 156 164
76. 2 FEBS J. 279 2012 636 649
77. X. Zhao, S.M. Jones, E.N. Yamoah, and Y.W. Lundberg Otoconin-90 deletion leads to imbalance but normal hearing: a comparison with other otoconia mutants Neuroscience 153 2008 289 299
78. 2-III as a biomarker candidate Br. J. Cancer 98 2008 587 595
79. 2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells Biochem. J. 387 2005 27 38
80. 2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells FEBS J. 272 2005 655 672
81. 2 enzymes in several human tissues Biochim. Biophys. Acta 1736 2005 200 210
82. 2 in human serum Biochim. Biophys. Acta 1733 2005 210 223
83. 2 Biochim. Biophys. Acta 1502 2000 257 263
84. 2 in gastric juice Scand. J. Clin. Lab. Invest. 62 2002 123 128
85. 2 group IIa gene polymorphism on phenotypic features of patients with familial adenomatous polyposis Dis. Colon Rectum 50 2007 223 231
86. 2IIa: results from the UDACS study Hum. Mol. Genet. 15 2006 355 361
87. 2-IIA: results from the UDACS study Hum. Mol. Genet. 16 2007 1437 1444
88. 2 group X gene: relevance to coronary artery disease J. Mol. Med. (Berl) 87 2009 723 733
89. 2, cause benign fleck retina Am. J. Hum. Genet. 89 2011 782 791
90. J.S. Friedman, B. Chang, D.S. Krauth, I. Lopez, N.H. Waseem, R.E. Hurd, K.L. Feathers, K.E. Branham, M. Shaw, G.E. Thomas, M.J. Brooks, C. Liu, H.A. Bakeri, M.M. Campos, C. Maubaret, A.R. Webster, I.R. Rodriguez, D.A. Thompson, S.S. Bhattacharya, R.K. Koenekoop, J.R. Heckenlively, and A. Swaroop Loss of lysophosphatidylcholine acyltransferase 1 leads to photoreceptor degeneration in rd11 mice Proc. Natl. Acad. Sci. U.S.A. 107 2010 15523 15528
91. S.G. Wilson, G. Adam, M. Langdown, R. Reneland, A. Braun, T. Andrew, G.L. Surdulescu, M. Norberg, F. Dudbridge, P.W. Reed, P.N. Sambrook, P.W. Kleyn, and T.D. Spector Linkage and potential association of obesity-related phenotypes with two genes on chromosome 12q24 in a female dizygous twin cohort Eur. J. Hum. Genet. 14 2006 340 348
92. 2-IID is associated with body weight loss in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 172 2005 1097 1104
93. B. Hoeft, J. Linseisen, L. Beckmann, K. Muller-Decker, F. Canzian, A. Husing, R. Kaaks, U. Vogel, M.U. Jakobsen, K. Overvad, R.D. Hansen, S. Knuppel, H. Boeing, A. Trichopoulou, Y. Koumantaki, D. Trichopoulos, F. Berrino, D. Palli, S. Panico, R. Tumino, H.B. Bueno-de-Mesquita, F.J. van Duijnhoven, C.H. van Gils, P.H. Peeters, V. Dumeaux, E. Lund, J.M. Huerta Castano, X. Munoz, L. Rodriguez, A. Barricarte, J. Manjer, K. Jirstrom, B. Van Guelpen, G. Hallmans, E.A. Spencer, F.L. Crowe, K.T. Khaw, N. Wareham, S. Morois, M.C. Boutron-Ruault, F. Clavel-Chapelon, V. Chajes, M. Jenab, P. Boffetta, P. Vineis, T. Mouw, T. Norat, E. Riboli, and A. Nieters Polymorphisms in fatty-acid-metabolism-related genes are associated with colorectal cancer risk Carcinogenesis 31 2010 466 472
94. 2 gene family polymorphisms and AIDS progression using the SNPlex method Biomed. Pharmacother. 62 2008 31 40
95. 2 inhibitors J. Med. Chem. 49 2006 6768 6778
96. 2 J. Med. Chem. 51 2008 4708 4714